Ki-67 mRNA as a predictor for response to neoadjuvant chemotherapy in primary breast cancer

被引：0
|
作者：
Marme, F.
Schneeweiss, A.
Aigner, J.
Eidt, S.
Altevogt, P.
Sinn, P.
Wirtz, R. M.
机构：
[1] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] St Elizabeth Hosp, Inst Pathol, Cologne, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Heidelberg Univ, D-69115 Heidelberg, Germany
[5] STRATIFYER MolecularPathol GmbH, Cologne, Germany
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P3-06-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-06-08
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
    Montagna, Emilia
    Bagnardi, Vincenzo
    Viale, Giuseppe
    Rotmensz, Nicole
    Sporchia, Andrea
    Cancello, Giuseppe
    Balduzzi, Alessandra
    Galimberti, Viviana
    Veronesi, Paolo
    Luini, Alberto
    Mastropasqua, Mauro G.
    Casadio, Chiara
    Sangalli, Claudia
    Goldhirsch, Aron
    Colleoni, Marco
    [J]. CANCER RESEARCH, 2015, 75
  • [32] Correlation between FLT-PET and Ki-67 change in breast cancer during neoadjuvant chemotherapy
    Blackman, S. C.
    Railkar, R. A.
    Fox, R.
    George, L.
    Iannone, R.
    Bergstrom, D. A.
    Mozley, P. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
    R J Burcombe
    A Makris
    P I Richman
    F M Daley
    S Noble
    M Pittam
    D Wright
    S A Allen
    J Dove
    G D Wilson
    [J]. British Journal of Cancer, 2005, 92 : 147 - 155
  • [34] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    [J]. MEDICINE, 2017, 96 (51)
  • [35] Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
    Burcombe, RJ
    Makris, A
    Richman, PI
    Daley, FM
    Noble, S
    Pittam, M
    Wright, D
    Allen, SA
    Dove, J
    Wilson, GD
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 147 - 155
  • [36] Survivin, Ki-67 and tumor grade as predictors of response to docetaxel-based neoadjuvant chemotherapy in locally advanced breast cancer
    Lin, Qi
    Liu, Yang
    Chen, Huiyu
    Liu, Yi
    Tang, Qiang
    Liu, Jing
    Chen, Hao
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (05) : 839 - 844
  • [37] Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.
    Farr, Alex
    Weber, Myriam
    Pfeiler, Georg
    Oppolzer, Elisabeth
    Salama, Mohammed
    Bago-Horvath, Zsuzsanna
    Seifert, Michael
    Singer, Christian F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] The role of Ki-67 in breast cancer
    Mannell, A.
    [J]. SOUTH AFRICAN JOURNAL OF SURGERY, 2016, 54 (02) : 10 - 13
  • [39] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Peter A Fasching
    Katharina Heusinger
    Lothar Haeberle
    Melitta Niklos
    Alexander Hein
    Christian M Bayer
    Claudia Rauh
    Ruediger Schulz-Wendtland
    Mayada R Bani
    Michael Schrauder
    Laura Kahmann
    Michael P Lux
    Johanna D Strehl
    Arndt Hartmann
    Arno Dimmler
    Matthias W Beckmann
    David L Wachter
    [J]. BMC Cancer, 11
  • [40] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    [J]. BMC CANCER, 2011, 11
12345